Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
Despite recent approvals, significant unmet need remains in Alzheimer’s market
Sarepta's DMD gene therapy inches closer to market as FDA declines to hold advisory meeting
Abbott heart valve deteriorates faster than rival device
*please scroll down for all the latest news*
